Cep250tm1b(EUCOMM)Wtsi
Targeted Allele Detail
|
|
| Symbol: |
Cep250tm1b(EUCOMM)Wtsi |
| Name: |
centrosomal protein 250; targeted mutation 1b, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:7444339 |
| Gene: |
Cep250 Location: Chr2:155798378-155840820 bp, + strand Genetic Position: Chr2, 77.26 cM
|
| Alliance: |
Cep250tm1b(EUCOMM)Wtsi page
|
| IMPC: |
Cep250 gene page |
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:326549
|
| Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
| Strain of Origin: |
C57BL/6N-Atm1Brd
|
| Project Collection: |
EUCOMM
|
|
| Allele Type: |
|
Targeted (Null/knockout, Reporter) |
| Mutations: |
|
Insertion, Intragenic deletion
|
| |
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 155806442 of Chromosome 2 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon(s) at position 155807664. The critical exon(s) is/are thus flanked by loxP sites. A null/knockout allele was created by cre recombinase expression in mice carrying the tm1a allele to remove the neo selection cassette and loxP-flanked critical exon(s). Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:326549)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Cep250 Mutation: |
100 strains or lines available
|
|
| Original: |
J:326549 Dang H, et al., Centrosome linker protein C-Nap1 maintains stem cells in mouse testes. EMBO Rep. 2022 Jul 5;23(7):e53805 |
| All: |
2 reference(s) |
|